Published in TB and Outbreaks Week, October 7th, 1996
Dr. H. Clifford Lane, U.S. NIAID, discussed the latest information on the use of IL-2 to boost CD4 cell production in AIDS patients at the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, held in New Orleans, Louisiana, September 15-18, 1996. Lane said that IL-2 therapy results in an expansion of the T-cell population that exists at that point, but with a slight preferential increase in "naive" cells over "memory" cells. Over time, he explained, "... you see more diversity in the repertoire."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week